Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio. 2010

Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
Graduate School for Infection Control, Kitasato University, Minato-ku, Tokyo, Japan

Human immunodeficiency virus (HIV) Gag precursor protein is cleaved by viral protease (PR) within GagPol precursor protein to produce the mature matrix (MA), capsid, nucleocapsid, and p6 domains. This processing is termed maturation and required for HIV infectivity. In order to understand the intracellular sites and mechanisms of HIV maturation, HIV molecular clones in which Gag and GagPol were tagged with FLAG and hemagglutinin epitope sequences at the C-termini, respectively were made. When coexpressed, both Gag and GagPol were incorporated into virus particles. Temporal analysis by confocal microscopy showed that Gag and GagPol were relocated from the cytoplasm to the plasma membrane. Mature cleaved MA was observed only at sites on the plasma membrane where both Gag and GagPol had accumulated, indicating that Gag processing occurs during Gag/GagPol assembly at the plasma membrane, but not during membrane trafficking. Fluorescence resonance energy transfer imaging suggested that these were the primary sites of GagPol dimerization. In contrast, with overexpression of GagPol alone an absence of particle release was observed, and this was associated with diffuse distribution of mature cleaved MA throughout the cytoplasm. Alteration of the Gag-to-GagPol ratio similarly impaired virus particle release with aberrant distributions of mature MA in the cytoplasm. However, when PR was inactive, it seemed that the Gag-to-GagPol ratio was not critical for virus particle release but virus particles encasing unusually large numbers of GagPol molecules were produced, these particles displaying aberrant virion morphology. Taken together, it was concluded that the Gag-to-GagPol ratio has significant impacts on either intracellular distributions of mature cleaved MA or the morphology of virus particles produced.

UI MeSH Term Description Entries
D011498 Protein Precursors Precursors, Protein
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014771 Virion The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Virus Particle,Viral Particle,Viral Particles,Particle, Viral,Particle, Virus,Particles, Viral,Particles, Virus,Virions,Virus Particles
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015683 Gene Products, gag Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. Viral gag Proteins,gag Antigen,gag Gene Product,gag Gene Products,gag Polyproteins,gag Protein,gag Viral Proteins,Gene Product, gag,Retroviral Antigen gag Protein,gag Antigens,gag Gene Related Protein,gag Polyprotein,Antigen, gag,Antigens, gag,Polyprotein, gag,Polyproteins, gag,Protein, gag,Proteins, Viral gag,Proteins, gag Viral,Viral Proteins, gag,gag Proteins, Viral
D015685 Fusion Proteins, gag-pol Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting. gag-pol Fusion Proteins,gag-pol Protein,gag-pol Fused Protein,Fused Protein, gag-pol,Fusion Proteins, gag pol,Protein, gag-pol,Protein, gag-pol Fused,Proteins, gag-pol Fusion,gag pol Fused Protein,gag pol Fusion Proteins,gag pol Protein
D055503 Protein Multimerization The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS. Protein Dimerization,Protein Heteromultimerizaton,Protein Multimer Assembly,Protein Trimerization,Assembly, Protein Multimer,Dimerization, Protein,Heteromultimerizaton, Protein,Heteromultimerizatons, Protein,Multimer Assembly, Protein,Multimerization, Protein,Trimerization, Protein
D057074 Virus Release Release of a virus from the host cell following VIRUS ASSEMBLY and maturation. Egress can occur by host cell lysis, EXOCYTOSIS, or budding through the plasma membrane. Virus Budding,Virus Egress,Budding, Virus,Egress, Virus,Release, Virus

Related Publications

Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
April 2003, Journal of virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
April 2006, Vaccine,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
June 1998, Journal of virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
October 1998, Journal of virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
September 2003, Journal of virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
June 2000, Journal of virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
March 1994, Virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
February 1995, Journal of virology,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
August 2011, The Journal of biological chemistry,
Hiyori Haraguchi, and Sho Sudo, and Takeshi Noda, and Fumitaka Momose, and Yoshihiro Kawaoka, and Yuko Morikawa
May 2004, Journal of virology,
Copied contents to your clipboard!